Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 23010705)

1.
2.

Potential prognostic tumor biomarkers in triple-negative breast carcinoma.

Peng Y.

Beijing Da Xue Xue Bao. 2012 Oct 18;44(5):666-72. Review.

4.

The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.

Tang D, Xu S, Zhang Q, Zhao W.

Med Oncol. 2012 Jun;29(2):526-33. doi: 10.1007/s12032-011-9948-2. Epub 2011 Apr 26.

PMID:
21519872
5.

Expression of androgen receptors in primary breast cancer.

Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH, Park BW, Lee KS.

Ann Oncol. 2010 Mar;21(3):488-92. doi: 10.1093/annonc/mdp510. Epub 2009 Nov 3.

6.

Expression of androgen receptor and its phosphorylated forms in breast cancer progression.

Ren Q, Zhang L, Ruoff R, Ha S, Wang J, Jain S, Reuter V, Gerald W, Giri DD, Melamed J, Garabedian MJ, Lee P, Logan SK.

Cancer. 2013 Jul 15;119(14):2532-40. doi: 10.1002/cncr.28092. Epub 2013 Apr 19.

8.

[Expression of androgen receptor in breast carcinoma and its relationship with estrogen receptor, progesterone receptor and HER2 status].

Chen J, Zhang X, Tian R, Liu Y, Dong HM, Guo RF, Liang HY.

Zhonghua Bing Li Xue Za Zhi. 2010 Nov;39(11):743-6. Chinese.

PMID:
21215164
9.

Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray.

He J, Peng R, Yuan Z, Wang S, Peng J, Lin G, Jiang X, Qin T.

Med Oncol. 2012 Jun;29(2):406-10. doi: 10.1007/s12032-011-9832-0. Epub 2011 Jan 25.

PMID:
21264529
10.

Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.

Tokunaga E, Hisamatsu Y, Taketani K, Yamashita N, Akiyoshi S, Okada S, Tanaka K, Saeki H, Oki E, Aishima S, Oda Y, Morita M, Maehara Y.

Cancer Med. 2013 Dec;2(6):763-73. doi: 10.1002/cam4.138. Epub 2013 Sep 30.

11.

Expression and clinical significance of androgen receptor in triple negative breast cancer.

Luo X, Shi YX, Li ZM, Jiang WQ.

Chin J Cancer. 2010 Jun;29(6):585-90.

12.

Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.

Tawfik K, Kimler BF, Davis MK, Fan F, Tawfik O.

Hum Pathol. 2012 Jan;43(1):23-30. doi: 10.1016/j.humpath.2011.04.011. Epub 2011 Jul 20.

PMID:
21777944
13.

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.

Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW, Lee KS.

Ann Oncol. 2011 Aug;22(8):1755-62. doi: 10.1093/annonc/mdq678. Epub 2011 Feb 10.

14.

Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.

Iwase H, Kurebayashi J, Tsuda H, Ohta T, Kurosumi M, Miyamoto K, Yamamoto Y, Iwase T.

Breast Cancer. 2010 Apr;17(2):118-24. doi: 10.1007/s12282-009-0113-0. Epub 2009 May 23.

PMID:
19466512
15.

Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.

Gonzalez LO, Corte MD, Junquera S, Bongera M, Rodriguez JC, Vizoso FJ.

Histopathology. 2007 Jun;50(7):866-74.

PMID:
17543076
16.

Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.

Lin Fde M, Pincerato KM, Bacchi CE, Baracat EC, Carvalho FM.

J Clin Pathol. 2012 Jan;65(1):64-8. doi: 10.1136/jclinpath-2011-200318. Epub 2011 Oct 29.

PMID:
22039288
17.

Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer.

Narita D, Raica M, Suciu C, Cîmpean A, Anghel A.

Folia Histochem Cytobiol. 2006;44(3):165-72.

18.

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers.

Ogawa Y, Hai E, Matsumoto K, Ikeda K, Tokunaga S, Nagahara H, Sakurai K, Inoue T, Nishiguchi Y.

Int J Clin Oncol. 2008 Oct;13(5):431-5. doi: 10.1007/s10147-008-0770-6. Epub 2008 Oct 23.

PMID:
18946753
19.

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.

Niemeier LA, Dabbs DJ, Beriwal S, Striebel JM, Bhargava R.

Mod Pathol. 2010 Feb;23(2):205-12. doi: 10.1038/modpathol.2009.159. Epub 2009 Nov 6.

20.

Expression of androgen receptors in triple negative breast carcinomas.

Mrklić I, Pogorelić Z, Capkun V, Tomić S.

Acta Histochem. 2013 May;115(4):344-8. doi: 10.1016/j.acthis.2012.09.006. Epub 2012 Sep 29.

PMID:
23031358
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk